AVIM Therapy (Atrioventricular Interval Modulation Therapy)
Hypertension (particularly in patients indicated for pacemakers)
Late-Stage Clinical (Pivotal)Investigational; BackBeat pivotal study ongoing
Key Facts
Indication
Hypertension (particularly in patients indicated for pacemakers)
Phase
Late-Stage Clinical (Pivotal)
Status
Investigational; BackBeat pivotal study ongoing
Company
About Orchestra BioMed
Orchestra BioMed is a publicly traded biomedical innovation company focused on developing high-impact therapeutic solutions for mature medical device markets with significant unmet needs. The company employs a partnership-enabled business model, forging strategic collaborations with leading medical device companies to drive global commercialization. Its two flagship technologies target hypertension and atherosclerotic artery disease, two of the world's leading causes of mortality, with late-stage product candidates designed for rapid adoption and strategic value creation.
View full company profile